Taken together, these findings suggest that SGLT2-dependent elevation of intracellular sodium and protons might act as a potential mediator of hyperglycemia-inhibited PGC-1α expression in diabetic nephropathy. Here, SLC5A2 is linked to diabetic kidney disease.